Old Web
English
Sign In
Acemap
>
authorDetail
>
Takayuki Kawai
Takayuki Kawai
Takeda Pharmaceutical Company
Chemistry
Pharmacology
Reuptake inhibitor
Antidepressant
Monoamine neurotransmitter
3
Papers
27
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
FTBMT, a Novel and Selective GPR52 Agonist, Demonstrates Antipsychotic-Like and Procognitive Effects in Rodents, Revealing a Potential Therapeutic Agent for Schizophrenia
2017
Journal of Pharmacology and Experimental Therapeutics
Keiji Nishiyama
Hirobumi Suzuki
Toshiya Harasawa
Noriko Suzuki
Emi Kurimoto
Takayuki Kawai
Minoru Maruyama
Hidetoshi Komatsu
Kensuke Sakuma
Yuji Shimizu
Masato Shimojo
Show All
Source
Cite
Save
Citations (15)
Design, synthesis, and biological activities of 1-aryl-1,4-diazepan-2-one derivatives as novel triple reuptake inhibitors.
2014
Bioorganic & Medicinal Chemistry Letters
Eiji Honda
Yuji Ishichi
Eiji Kimura
Masato Yoshikawa
Naoyuki Kanzaki
Hideyuki Nakagawa
Yasuko Terao
Atsuko Suzuki
Takayuki Kawai
Yuuichi Arakawa
Hiroyuki Ohta
Jun Terauchi
Show All
Source
Cite
Save
Citations (3)
Novel triple reuptake inhibitors with low risk of CAD associated liabilities: design, synthesis and biological activities of 4-[(1S)-1-(3,4-dichlorophenyl)-2-methoxyethyl]piperidine and related compounds.
2013
Bioorganic & Medicinal Chemistry
Yuji Ishichi
Eiji Kimura
Eiji Honda
Masato Yoshikawa
Takashi Nakahata
Yasuko Terao
Atsuko Suzuki
Takayuki Kawai
Yuuichi Arakawa
Hiroyuki Ohta
Naoyuki Kanzaki
Hideyuki Nakagawa
Jun Terauchi
Show All
Source
Cite
Save
Citations (9)
1